Rapid Microbiology Testing Market - Trends Forecast Till 2028

Market Overview

Rapid Microbiology Testing Market by Product (Reagents, Kits, Automated Identification System, PCR, Mass Spectrometry), Method (Growth, Nucleic Acid, Viability), Applications (Clinical Diagnosis, Pharma, Environmental) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

The global rapid microbiology testing market is projected to reach USD 6.7 billion by 2026 from USD 4.2 billion in 2021, at a CAGR of 9.4% in the forecast period 2021-2028

Increased focus on the early detection of infectious disease, technological advancements, increased funding for R&D and increasing incidence of infectious disease are some of the factors that have supported long-term expansion for Rapid Microbiology Testing Market.

Key Findings

Rapid Microbiology Testing Market is segmented into product, method, application and geography.

Product segment is segmented into instruments, reagents and kits and consumables.

Method segment is segmented into Growth-Based Rapid Microbiology Testing, Cellular component-based Rapid Microbiology Testing, Nucleic Acid-Based Rapid Microbiology Testing and Viability-Based Rapid Microbiology Testing.

Applications segment is segmented into Clinical Disease Diagnostics, Food & Beverage testing, Pharmaceutical & Biological Drug Testing, Environmental Testing, Cosmetics and Personal Care Products Testing and Research Applications.

Geographically, Rapid Microbiology Testing Market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Competitive Landscape

Key players in Rapid Microbiology Testing Market are Abbott Laboratories, Inc. (US), Becton, Dickinson and Company (US), bioMérieux SA (France), Bruker Corporation (US), Charles River Laboratories International, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), NEOGEN Corporation (US), Quidel Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), Don Whitley Scientific Limited (UK), Rapid Micro Biosystems, Inc. (US), Vivione Biosciences, LLC (US), Gradientech (Sweden), rqmicro AG (Switzerland), Bactest Ltd. (US), Colifast (Norway), Serosep Ltd. (Ireland), Biosensia (Ireland), Solus Scientific Solutions Ltd. (Scotland), LubioScience GmbH (Scotland), Euroclone SpA (Italy), CorDx (US), and R-Biopharm AG (Germany).

Reasons to Acquire

• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
• Gain authentic and granular data access for rapid microbiology testing market so as to understand the trends and the factors involved behind changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope